EMP16-02
AssetSmall molecule
Inhibits alpha-glucosidase and pancreatic lipase to reduce carbohydrate and fat absorption.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- Indications
- 3
- Trials
- 49
- Developers
- 1
Indications
3Obesity & overweight
Phase 2NOT_YET_RECRUITINGNCT06993428clinicaltrials.gov7 Oct 2026
Overweight or obese
Phase 2NOT_YET_RECRUITINGNCT06993428clinicaltrials.gov7 Oct 2026
Overweight or obesity
Phase 1COMPLETEDNCT04521751clinicaltrials.gov7 Oct 2026
- Targets and what it contains5
- Owner and partners1
- Trials49
- Evidence for its targets4
- Competitors11
- Aging relevance3
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 5 sources